Chattanooga Intelect Neo, Руководство пользователя

Страница: 82 / 84

80
Intelect® Neo Clinical Therapy System
ELECTROMAGNETIC COMPATIBILITY ( EMC ) TABLES
Guidance and Manufacturer’s Declaration - Electromagnetic Immunity
The Intelect Neo Clinical Therapy System is intended for use in the electromagnetic environment speci fi ed below. The
customer or the user of the Intelect Neo Clinical Therapy System should assure that it is used in such an environment
Immunity Test IEC 60601
Test Level
Compliance Level Electromagnetic Environment -
Guidance
Portable and mobile RF communications
equipment should be used no closer to any
part of the Intelect Neo Clinical Therapy System,
including cables, than the recommended
separation distance calculated from the
equation applicable to the frequency of the
transmitter.
Recommended separation distance
Conducted RF
IEC 61000-4-6
3 Vrms
150 kHz to 80 MHz
3V d = [3,5] √ P
V1
Radiated RF
IEC 61000-4-3
3 V/m
80 MHz to 2,5 GHz
3V/m d = [3,5] √ P 80 MHz to 800 MHz
E
1
d = [7] √ P 800 MHz to 2,5 GHz
E
1
Guidance and Manufacturer’s Declaration - Electromagnetic Immunity
Immunity Test IEC 60601
Test Level
Compliance Level Electromagnetic Environment -
Guidance
Where P is the maximum output power rating
of the transmitter in watts (W) according to
the transmitter manufacturer and d is the
recommended separation distance in metres
(m).
Field strengths from fi xed RF transmitters, as
determined by an electromagnetic site survey
a
,
should be less than the compliance level in each
frequency range
b
. Interference may occur in the
vicinity of equipment marked with the following
symbol:
NOTE 1 At 80 MHz and 800 MHz, the higher frequency range applies.
NOTE 2 These guidelines may not apply in all situations. Electromagnetic propagation is a ff ected by absorption and re fl ection from structures,
objects and people.
a
Field strengths from fi xed transmitters, such as base stations for radio (cellular/cordless) telephones and land mobile radios, amateur radio, AM
and FM radio broadcast and TV broadcast cannot be predicted theoretically with accuracy. To assess the electromagnetic environment due to
fi xed RF transmitters, an electromagnetic site survey should be considered. If the measured fi eld strength in the location in which the Intelect Neo
Clinical Therapy System is used exceeds the applicable RF compliance level above, theIntelect Neo Clinical Therapy System should be observed to verify
normal operation. If abnormal performance is observed, additional measures may be necessary, such as reorienting or relocating the Intelect Neo
Clinical Therapy System.
b
Over the frequency range 150 kHz to 80 MHz, fi eld strengths should be less than [V
1
] V/m.
APPENDIX